Cargando…
Adoptive cell therapy using tumor‐infiltrating lymphocytes for melanoma refractory to immune‐checkpoint inhibitors
To evaluate the feasibility of adoptive cell therapy (ACT) using ex vivo‐expanded tumor‐infiltrating lymphocytes (TILs) in Japanese patients with melanoma who failed immune‐checkpoint inhibitor therapy, an open‐label, single‐arm, pilot study was conducted. We investigated the immunological and genet...
Autores principales: | Hirai, Ikuko, Funakoshi, Takeru, Kamijuku, Hajime, Fukuda, Keitaro, Mori, Mariko, Sakurai, Masatoshi, Koda, Yuya, Kato, Jun, Mori, Takehiko, Watanabe, Naohide, Noji, Shinobu, Yaguchi, Tomonori, Iwata, Takashi, Ohta, Shigeki, Fujita, Tomonobu, Tanosaki, Ryuji, Handa, Makoto, Okamoto, Shinichiro, Amagai, Masayuki, Kawakami, Yutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353905/ https://www.ncbi.nlm.nih.gov/pubmed/34101300 http://dx.doi.org/10.1111/cas.15009 |
Ejemplares similares
-
Imatinib mesylate in combination with pembrolizumab in patients with advanced KIT-mutant melanoma following progression on standard therapy: A phase I/II trial and study protocol
por: Hirai, Ikuko, et al.
Publicado: (2021) -
Periostin Is a Key Niche Component for Wound Metastasis of Melanoma
por: Fukuda, Keitaro, et al.
Publicado: (2015) -
Updates on the Systemic Treatment of Advanced Non-melanoma Skin Cancer
por: Tanese, Keiji, et al.
Publicado: (2019) -
CHD7 promotes proliferation of neural stem cells mediated by MIF
por: Ohta, Shigeki, et al.
Publicado: (2016) -
Comparison of basophil activation test and lymphocyte transformation test as diagnostic assays for drug hypersensitivity
por: Adachi, Takeya, et al.
Publicado: (2014)